This model is consistent with the well-established multi-step carcinogenesis model of CRC12, in which mutations in major driver genes such as APC, KRAS, and TP53 are sequentially accumulated in adenoma and then additional CNAs are acquired during the progression from adenoma to carcinoma. The gene discussed is KRAS; the disease is adenoma.